Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study

Constantinos Koshiaris, Paul Aveyard, Jason Oke, Ronan Ryan, Lisa Szatkowski, Richard Stevens, Amanda Farley

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


The aim was to examine the association between smoking cessation and prognosis in smoking-related cancer as it is unclear that cessation reduces mortality.

In this retrospective cohort study from 1999 to 2013, we assessed the association between cessation during the first year after diagnosis and all-cause and cancer-specific mortality.

Of 2,882 lung, 757 upper aero-digestive tract and 1,733 bladder cancer patients 27%, 29% and 21% of lung, UAT and bladder cancer patients quit smoking. In lung cancer patients that quit, all-cause mortality was significantly lower (HR 0.82 (0.74-0.92), while cancer-specific mortality (HR 0.89 (0.76-1.04) and death due to index cancer (HR 0.90 (0.77-1.05) were non-significantly lower. In UAT cancer, all-cause mortality (HR 0.81 (0.58-1.14), cancer-specific mortality (HR 0.84 (0.48-1.45), and death due to index cancer (HR 0.75 (0.42-1.34) were non-significantly lower. There was no evidence of an association between quitting and mortality in bladder cancer. The HRs were 1.02 (0.81-1.30) for all-cause, 1.23 (0.81-1.86) for cancer specific, and 1.25 (0.71-2.20) for death due to index cancer. These showed a non-significantly lower risk in sensitivity analyses.

People with lung and possibly UAT cancer who quit smoking have a lower risk of mortality than people who continue smoking.
Original languageEnglish
Pages (from-to)1224-1232
JournalBritish Journal of Cancer
Early online date12 Sept 2017
Publication statusPublished - 10 Oct 2017


  • cancer
  • primary care
  • smoking
  • smoking cessation


Dive into the research topics of 'Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study'. Together they form a unique fingerprint.

Cite this